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A 8lucosyitransferase catatysing formation of bile acid glucosides was recently isolated from human liver 
microsomes. In order to investigate the potential occurrence of such bile acid derivatives in viva, a method 
was devised for their isolation and purification from urine. Conditions were established with the aid of glu- 
cosides of radiolabelled, unconjugated glycine and taurine conjugated bile acids prepared enzymaticaity us- 
ing human liver microsomes. Analysis by gas chromatography and mass spectrometry of methyl ester tri- 
methylsilyl ether derivatives indicated the excretion of glucosides of nonamidated hyodeoxycholic, chenode- 
oxycholic, deoxycholic, ursodeoxycholic and cholic acids and of glycine and taurine conjugated chenode- 
oxycholic and cholic acids. Additional compounds were present giving mass spectral fragmentation patterns 
typical of di- and trihydroxy bile acid glycosides. Semiquantitative stimates indicated a total daily excretion 
of about 1 pmol. 
Bile acid; Glucoside; Microsome; (Human liver, Urine) 
1. INTRO~UCTrON 
Formation of bile acid glucosides was recently 
shown to be a novel reaction of bile acids [I] in ad- 
dition to the known conjugation with amino acids 
[2], sulphuric acid [3] and glucuronic acid [4,5]. A 
glucosyltransferase catalyzing the transfer of 
glucose from lipophilic alkyl-&D-glucopyrano- 
sides or dolichol monophosphate glucose to bile 
acids could be isolated and further characterized 
from human liver microsomes [l]. Evidence for the 
existence of these novel bile acid conjugates in vivo 
was lacking. The present paper describes the detec- 
tion of glucosides of several unconjugated bile 
acids, and provides evidence for the occurrence of 
glucosides of glycine and taurine conjugated bile 
acids in urine of healthy humans. 
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2. MATERIALS AND METHODS 
2.1. Muferials 
Human liver samples were obtained from organ 
donors within 30 min after cessation of life sup- 
port and were perfused with cold 0.9% NaCl. The 
samples were stored, homogenized and 
microsomes were prepared as described [6]. Only 
tissues with apparently normal histology were 
used. 
All labelled and unlabelled bile acids were ob- 
tained as described [7], except for [24-‘4C]hyo- 
deoxychoIic acid (1.2 pCi/pmol) which was a kind 
gift of Dr M. Parquet (Paris, France). Lipidex- 
DEAP and Lipidex 5000 were from Packard- 
Becker (Groningen, The Netherlands), Sepralyte 
Cl8 from Analytichem (Harbor City, USA), and 
Sep-Pak CIS cartridges from Waters Associates 
(Milford, USA). All other chemicals and condi- 
tions used for determination of radioactivity by li- 
quid scintillation counting and thin-layer scanning 
were the same as described [7-91. 
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2.2. Preparation of bile acid glucosides 
Using preparations of human liver microsomes 
[61, “C-labelled glucosides of chenodeoxycholic 
(CDCAgluc), hyodeoxycholic (HDCAgluc), deox- 
ycholic (DCAgluc) and cholic (CAgluc) acids and 
3H-labelled ursodeoxycholic acid glucoside 
(UDCAgluc) were synthesized as reference com- 
pounds by enzymatic conjugation of the respective 
bile acid with octyl-P-D-glucopyranoside as 
described [ 11. Using the same conditions, 
[‘4C]glycocholic acid glucoside (GCAgluc) and 
tauro-[14C]cholic acid glucoside (TCAgluc) were 
also synthesized from the respective amino acid 
conjugates. Hyodeoxycholic acid [14C]glucuronide 
(HDCAglucA) was prepared for reference pur- 
poses by enzymatic conjugation of hyodeoxycholic 
acid with UDP-[14C]glucuronic acid [7]. The bile 
acid conjugates were purified by ion-exchange 
chromatography on Lipidex-DEAP [8] and, after 
methylation, by straight-phase chromatography on 
Lipidex 5000 (see analysis of urine) [9]. GCAgluc 
and TCAgluc were treated with cholylglycine 
hydrolase [ 101, and rechromatographed on 
Lipidex-DEAP before methylation and chroma- 
tography on Lipidex 5000. Purification steps were 
monitored by gas-liquid chromatography (GLC) 
after methylation with diazomethane and conver- 
sion into trimethylsilyl (TMS) ether derivatives [8]. 
2.3. Analysis of urine 
Six different 24 h urine samples from healthy 
humans were analysed. After centrifugation and 
filtration, 1 1 of each urine sample was extracted 
with Sep-Pak Cl8 using one cartridge for each 
125 ml. Bile acids were eluted with 10 ml of 80% 
methanol. The eluates were combined, evaporated 
and dissolved in 30 ml water. This solution was ex- 
tracted with a Sep-Pak Cr8 cartridge, and the 80% 
methanol eluate was reextracted in the same way 
twice after evaporation of the methanol. The bile 
acids were eluted with 5 ml of 70% ethanol in the 
third extraction. This eluate was directly subjected 
to chromatography on Lipidex-DEAP [8]. Frac- 
tions containing glycine, taurine and sulphate con- 
jugates were treated with cholylglycine hydrolase 
[lo] and, after extraction with Sep-Pak c18, 
rechromatographed on Lipidex-DEAP. The un- 
conjugated bile acids and bile acid glucosides were 
eluted with 0.1 M acetic acid in 70% ethanol and 
the glucuronides with 0.25 M formic acid in the 
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same solvent [l 11. After extraction with Sep-Pak 
cl8 and methylation, glucosides and glucuronides 
were finally purified by chromatography on 
Lipidex 5000. Unconjugated bile acid methyl esters 
and other contaminants were eluted with 
chloroform/hexane 1: 4- 1: 1 (v/v) [9], and methyl 
esters of bile acid glucosides or glucuronides were 
then recovered with methanol. 
2.4. Gas-liquid chromatography and mass 
spectrometry 
GLC was performed using a Carlo-Erba HRGC 
instrument with a fused silica capillary column 
(Quadrex, 25 m x 0.32 mm, cross linked methyl 
silicone, 0.25 pm film thickness) and a flame 
ionization detector. After injection at 60°C the 
temperature was increased at 30”C/min to 300°C. 
Helium carrier gas pressure was -100 kPa. Ap- 
propriate n-hydrocarbons were added for deter- 
mination of retention indices (RI). 
A VG 7070E double focussing mass spec- 
trometer and a DS 2350 data system was used for 
fast atom bombardment mass spectrometry 
(FABMS) and gas chromatography-mass pec- 
trometry (GCYMS). FAB spectra were recorded in 
the negative ion mode. In GC/MS, spectra were 
recorded by scanning the range m/z 750-20 at a 
rate of 2 s/decade, using the same column as 
described above. The electron energy was 22.5 eV. 
3. RESULTS AND DISCUSSION 
3.1. Characterization of bile acid glucosides 
prepared in vitro 
Enzymatically prepared bile acid glucosides were 
eluted from Lipidex-DEAP together with uncon- 
jugated bile acids using 0.1 M acetic acid in 70% 
methanol. They were separated from bile acid 
glucuronides, which were eluted with 0.15 M am- 
monium acetate, pH 6.6, together with taurine 
conjugated bile acids (81, or with 0.25 M formic 
acid [l 11. GCAgluc and TCAgluc were eluted in 
the fractions containing glycine and taurine con- 
jugates, respectively [8]. After treatment with 
cholylglycine hydrolase [lo], the resulting CAgluc 
was obtained in the 0.1 M acetic acid fraction. 
The conjugation of chenodeoxycholic and 
hyodeoxycholic acids with glucose and glucuronic 
acid, respectively, was established by negative ion 
FABMS. Quasi molecular ions, [M - l]-? were ob- 
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Fig.1. Upper mass region of the negative ion FAB mass spectra of ~henodeoxy~holic acid giucoside (left) and 
hyodeoxy~holic acid glucuronide (right). 
tained at the expected masses: m/z 553 for 
CDCAgluc and m/z 567 for HDCAglucA (fig.1). 
The chromatographic behaviour on Lipidex- 
DEAP shows that the sugar moiety of all the 
glucosides prepared was attached at a ring position 
and not at C-24. 
The retention indices of the methyl ester TMS 
ether derivatives of the enzymatically prepared 
compounds were 4238 for HDCAgluc, 4296 for 
UDCAgluc, 4354 for DCAgluc, 4377 for 
CDCAgluc, and 4433 for CAgluc. The mass spec- 
tra of these derivatives showed characteristic 
fragmentation patterns. In each case, ions at m/z 
204 and 217 derived from the glucose moiety were 
intense, The derivatives of the glucosides of 
CDCA, HDCA, DCA and UDCA showed ions at 
m/z 371 and 461, and that of CA at m/z 549,459 
and 369. These are fragment ions typical of the 
derivatives of di- and trihydroxy bile acid 
glycosides formed by losses of the sugar moiety 
and trimethylsilanol 1121. 
3.2. Characterization of bile acids in urine 
Potential glucosides of unconjugated bile acids 
in urine were purified by chromatography on 
Lipidex-DEAP and, following methylation, on 
Lipidex 5000 using conditions established with the 
reference bile acid glucosides. GLC of the methyl 
ester TMS ether derivatives from each urine sam- 
ple showed a typical pattern of at least nine peaks 
with retention indices between 4198 and 4538 
(fig.2). GClMS analysis showed that each peak 
gave a fragmentation pattern typical of derivatives 
of di- or trihydroxy bile acid glucosides. Com- 
parison of fragmentation patterns and retention 
indices indicated the presence of glucosides of 
CDCA, DCA, HDCA, UDCA and CA in normal 
urine. However, the major peaks did not corre- 
spond to any of the known bile acid glucosides, 
lee C SCAN 
98 38 41 
88 40 83 
44 22s 
m 
68 
58 
4* 
38 
Fig.2. Total ion current chromatograms of methyl esters 
TMS ether derivatives obtained in the GC/MS analysis 
of a urine sample after purification (cf. text). Upper 
panel (A), derivatives of glucosides of unconjugated bile 
acids; lower panel (B), derivatives of bile acid glucosides 
obtained after hydrolysis of the glycine-conjugate 
fraction from Lipidex-DEAP with cholylgiycine 
hydrofase. No further peaks appeared after scan 330 (A) 
and 255 (B). For comp~ison of retention indices, scan 
numbers are given for three n-hydrocarbon standards 
(A) and for the enzymatically prepared reference 
compounds (B). 
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and not ail of them were found in each urine 
sample. 
Fractions from Lipidex-DEAP containing 
glycine and taurine conjugated bile acids were 
treated with cholylglycine hydrolase, followed by 
purification and derivatization as described for 
glucosides of the unconjugated bile acids. GLC 
and GC/MS showed the presence of bile acid 
glucosides in the glycine (fig.2), and to a lesser ex- 
tent in the taurine conjugate fractions. CDCAgluc 
and CAgluc were the major compounds. Thus, bile 
acid conjugates cont~n~ng both glucose and amino 
acid (preferably glycine) moieties seem to be nor- 
mal constituents in human urine. 
The total area of the GLC peaks identified by 
retention indices and fragmentation patterns to be 
derivatives of bile acid glucosides was compared 
with the peak areas of known amounts of the en- 
zymatically prepared reference compounds. The 
excretion of bile acid glucosides was estimated to 
be about I ,umol/day, i.e. in the same range as that 
of bile acid glucuronides in healthy subjects [12]. 
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